Biote Q1 2024 GAAP EPS $(0.06) Misses $0.03 Estimate, Sales $46.804M Beat $45.711M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biote (NASDAQ:BTMD) reported Q1 2024 earnings with a GAAP EPS of $(0.06), missing the $0.03 estimate, but sales of $46.804M exceeded the $45.711M forecast. This represents a significant improvement in losses and a slight increase in sales compared to the same period last year.
May 07, 2024 | 9:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Biote reported a Q1 2024 GAAP EPS of $(0.06), missing estimates, but sales of $46.804M exceeded expectations, showing improvement over the previous year.
While the EPS miss might concern some investors, the sales beat and significant improvement over last year's losses could be seen positively. The mixed results make the short-term impact neutral as investors weigh the positives against the EPS miss.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90